Literature DB >> 22286692

MIP-3α expression in macrophages is NOD dependent.

M Hausmann1, C Zeitler, A Weber, M Krebs, S Kellermeier, P Rosenstiel, C de Vallière, K Kosovac, M Fried, E Holler, G Rogler.   

Abstract

BACKGROUND: The first identified susceptibility gene for Crohn's disease, NOD2, acts as a sensor for the bacterial-wall peptidoglycan fragment muramyl dipeptide (MDP) and activates the transcription factor nuclear factor-κB (NF-κB). Upon NF-κB activation, intestinal macrophages (IMACs) induce expression of macrophage inflammatory protein (MIP)-3α to attract memory T lymphocytes. We therefore investigated the influence of NOD2 ligation of IMAC differentiation and functional MIP-3α induction.
METHODS: Human embryonal kidney HEK293 cells were transfected with NOD2 wild-type (NOD2(WT)) and the NOD2 SNP13 variant (NOD2(L1007fsinsC)) and stimulated with MDP. Recruitment of CD45R0+ and Th17 cells was determined by immunohistochemistry.
RESULTS: Endogenous NOD2 stimulation was followed by a dose-dependent increase in MIP-3α secretion in MONO-MAC-6 (MM6) cells. MIP-3α mRNA was also significantly (*p < 0.05) induced in HEK293 transfected with NOD2(WT) via MDP ligation. In vivo cell-cell contacts between IMACs and CD45R0+ memory T cells as well as recruitment of Th17 cells in patients of NOD2 variants were unchanged as compared to wild-type patients.
CONCLUSION: Our data demonstrate a dose-dependent increase in MIP-3α secretion in the human myeloid cell line MM6 upon MDP. However, MIP-3α-driven recruitment of Th17 cells or CD45R0+ memory T lymphocytes is not affected in patients carrying heterozygous NOD2 variants.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286692     DOI: 10.1159/000335423

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.

Authors:  Tejas S Lahoti; Jacob A Boyer; Ann Kusnadi; Gulsum E Muku; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2015-08-10       Impact factor: 4.849

2.  Relationship between serum and synovial fluid CCL20 concentrations with disease severity in primary knee osteoarthritis.

Authors:  Jian Guan; Yao Li; Luo-Bin Ding; Guang-Yuan Liu; Xiao-Fei Zheng; Wei Xue; Hua-Jun Wang
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-09-01       Impact factor: 2.041

3.  C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release.

Authors:  Helene Kolstad Skovdahl; Jan Kristian Damås; Atle van Beelen Granlund; Ann Elisabet Østvik; Berit Doseth; Torunn Bruland; Tom Eirik Mollnes; Arne Kristian Sandvik
Journal:  Int J Mol Sci       Date:  2018-10-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.